Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Genetic Disease | Family Medicine
Disease Category: Bipolar Disorder
Location: United States, IL
A double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with acute mania associated with Bipolar I Disorder
To evaluate the efficacy, safety, and tolerability of cariprazine monotherapy
versus placebo for the treatment of acute manic or mixed episodes associated
with bipolar I disorder. For safety reasons, patients will be asked to be
hospitalized during the screening phase and for a minimum of 2 weeks during
the treatment period.
Please contact Alexian Brothers for more information on participation.
Alexian Brothers Hospital Network
1786 Moon Lake Blvd, Suite 200
Hoffman Estates, IL 60169
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these